The reasons minority participants avoid clinical trials are well documented. Historical lack of consent,  little diversity within the research team, and a percieved lack of relevance could all seem to push patients away. But researchers are working with community leaders, introducing trial navigators and working with doctors who have many patients from minority communities are all efforts that are being employed to turn the tide. A diverse trial population will ensure that the results more accurately reflect needs of the population as a whole.